NOVARTIS N Valuation
| NOT Stock | EUR 141.86 0.54 0.38% |
At this time, the firm appears to be undervalued. NOVARTIS N secures a last-minute Real Value of €158.04 per share. The latest price of the firm is €141.86. Our model forecasts the value of NOVARTIS N from reviewing the firm fundamentals such as Price To Sales of 4.69 X, current valuation of 239.79 B, and Price To Book of 5.99 X as well as analyzing its technical indicators and probability of bankruptcy.
Price Book 5.9857 | Enterprise Value 239.8 B | Enterprise Value Ebitda 12.3808 | Price Sales 4.6907 | Forward PE 14.0647 |
Undervalued
Today
Please note that NOVARTIS N's price fluctuation is very steady at this time. Calculation of the real value of NOVARTIS N is based on 3 months time horizon. Increasing NOVARTIS N's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
NOVARTIS N's intrinsic value may or may not be the same as its current market price of 141.86, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 141.86 | Real 158.04 | Hype 141.78 | Naive 142.04 |
The intrinsic value of NOVARTIS N's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence NOVARTIS N's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of NOVARTIS N helps investors to forecast how NOVARTIS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of NOVARTIS N more accurately as focusing exclusively on NOVARTIS N's fundamentals will not take into account other important factors: NOVARTIS N Cash |
|
About NOVARTIS N Valuation
The stock valuation mechanism determines NOVARTIS N's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of NOVARTIS N based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of NOVARTIS N. We calculate exposure to NOVARTIS N's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of NOVARTIS N's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 43 B | 38.4 B |
NOVARTIS N Quarterly Retained Earnings |
|
Additional Tools for NOVARTIS Stock Analysis
When running NOVARTIS N's price analysis, check to measure NOVARTIS N's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NOVARTIS N is operating at the current time. Most of NOVARTIS N's value examination focuses on studying past and present price action to predict the probability of NOVARTIS N's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NOVARTIS N's price. Additionally, you may evaluate how the addition of NOVARTIS N to your portfolios can decrease your overall portfolio volatility.